ABOS
Price
$1.20
Change
+$0.13 (+12.15%)
Updated
Jun 6 closing price
Capitalization
64.51M
71 days until earnings call
ACHV
Price
$3.83
Change
+$0.30 (+8.50%)
Updated
Jun 6 closing price
Capitalization
122.26M
60 days until earnings call
Interact to see
Advertisement

ABOS vs ACHV

Header iconABOS vs ACHV Comparison
Open Charts ABOS vs ACHVBanner chart's image
Acumen Pharmaceuticals
Price$1.20
Change+$0.13 (+12.15%)
Volume$383.45K
Capitalization64.51M
Achieve Life Sciences
Price$3.83
Change+$0.30 (+8.50%)
Volume$244.73K
Capitalization122.26M
ABOS vs ACHV Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ACHV commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a StrongBuy and ACHV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ABOS: $1.02 vs. ACHV: $3.15)
Brand notoriety: ABOS and ACHV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 158% vs. ACHV: 75%
Market capitalization -- ABOS: $64.51M vs. ACHV: $122.26M
ABOS [@Biotechnology] is valued at $64.51M. ACHV’s [@Biotechnology] market capitalization is $122.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileACHV’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ACHV’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 1 TA indicator(s) are bullish while ACHV’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 1 bullish, 4 bearish.
  • ACHV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -1.92% price change this week, while ACHV (@Biotechnology) price change was +0.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

ACHV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($122M) has a higher market cap than ABOS($64.5M). ACHV YTD gains are higher at: -10.511 vs. ABOS (-40.698). ACHV has higher annual earnings (EBITDA): -37.42M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. ACHV (34.3M). ACHV has less debt than ABOS: ACHV (9.96M) vs ABOS (28.5M). ABOS (0) and ACHV (0) have equivalent revenues.
ABOSACHVABOS / ACHV
Capitalization64.5M122M53%
EBITDA-77.89M-37.42M208%
Gain YTD-40.698-10.511387%
P/E RatioN/AN/A-
Revenue00-
Total Cash200M34.3M583%
Total Debt28.5M9.96M286%
FUNDAMENTALS RATINGS
ACHV: Fundamental Ratings
ACHV
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSACHV
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
87%
Momentum
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
80%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
71%
Advances
ODDS (%)
Bullish Trend 24 days ago
77%
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with ATOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
N/A
ATOS - ABOS
50%
Loosely correlated
-3.13%
CRBU - ABOS
49%
Loosely correlated
+2.75%
BEAM - ABOS
49%
Loosely correlated
-0.88%
FHTX - ABOS
49%
Loosely correlated
+6.17%
ABCL - ABOS
48%
Loosely correlated
+3.03%
More

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been closely correlated with HOFBF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACHV jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-0.32%
HOFBF - ACHV
72%
Closely correlated
N/A
ABOS - ACHV
43%
Loosely correlated
N/A
EYPT - ACHV
40%
Loosely correlated
+18.12%
ERAS - ACHV
40%
Loosely correlated
+1.85%
ATOS - ACHV
39%
Loosely correlated
-3.13%
More